Question 1

Has Clara Hwang, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $4,184,966 in general payments to Clara Hwang, MD across 510 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Clara Hwang, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Clara Hwang, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Merck	282	$2,268,997
Astrazeneca UK Limited	5	$572,872
Seagen Inc.	57	$377,167
Exelixis Inc.	25	$260,711
AstraZeneca	20	$215,906
Taiho Oncology, Inc.	51	$157,305
Bayer	37	$156,230
Amgen	1	$108,404
Macrogenics, Inc.	3	$42,080
Pfizer	9	$14,367
EMD Serono, Inc.	2	$3,951
Astellas Pharma Global Development	1	$1,875
Janssen Scientific Affairs, LLC	2	$1,783
Johnson & Johnson	1	$1,363
Novartis	2	$1,179
Dendreon Pharmaceuticals LLC	6	$283
Merz North America, Inc.	2	$191
Telix Pharmaceuticals	1	$133
E.r. Squibb & Sons, L.L.C.	2	$111
Genentech, Inc.	1	$57

Clara Hwang, MD

Payments from drug & device makers

Who reported the general payments

How this compares

Medicare billing

Other medical oncology in Detroit